Preconcepción

Durante el embarazo

Post-embarazo

Validación y evidencia

Validamos nuestro test con estudios clínicos y hacemos los datos públicamente disponibles.

Publicaciones revisadas por pares
> 0

Calidad y Precisión

Cumplimos o superamos los estándares aplicables de la industria y regulaciones para todas nuestras pruebas en laboratorios

certificados por CLIA

Acreditados por CAP

Soporte y Transparencia

Proveemos soporte de expertos para ayudarte a que nuestros resultados de pruebas sean más claros y fáciles de entender.

sesiones de soporte a pacientes anualmente
> 0 K

Realizadas por profesionales con equipos de alta tecnología avalados por proveedores internacionales especialistas en el área

Major depressive disorder (MDD) is one of the most prevalent mood disorders worldwide. The World Health Organization (WHO) reports that more than 300 million people
Depression is a significant health and economic burden in Canada. In addition to the impact of depression on patients’ health and quality of life [1],
Using pharmacogenetics in guiding drug therapy experiences a steady increase in uptake, although still leads to discussions as to its clinical use. Psychiatry constitutes a
Predictors of treatment outcome in major depressive disorder (MDD) could contribute to evidence-based therapeutic choices. Combined pharmacotherapy and psychotherapy show increased efficacy but higher cost
Automation has been introduced into variant interpretation, but it is not known how automated variant interpretation performs on a stand- alone basis. The purpose of
HBB-related significant hemoglobinopathies have been anecdotally associated with low fetal fraction on noninvasive prenatal screening (NIPS). We sought to compare the difference in fetal fraction